Provided by Tiger Trade Technology Pte. Ltd.

Monte Rosa Therapeutics

19.55
+0.65003.44%
Post-market: 19.550.00000.00%19:56 EST
Volume:1.36M
Turnover:26.86M
Market Cap:1.49B
PE:77.45
High:20.29
Open:19.27
Low:19.10
Close:18.90
52wk High:25.77
52wk Low:3.50
Shares:76.24M
Float Shares:24.48M
Volume Ratio:1.17
T/O Rate:5.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2524
EPS(LYR):-0.9836
ROE:9.28%
ROA:1.37%
PB:6.06
PE(LYR):-19.88

Loading ...

13D Filings -- Barrons.com

Dow Jones
·
Jan 17

Monte Rosa Therapeutics Price Target Raised to $37.00/Share From $27.50 by Piper Sandler

Dow Jones
·
Jan 14

Monte Rosa Therapeutics CEO Markus Warmuth Reports Sale of Common Shares

Reuters
·
Jan 10

BUZZ-U.S. STOCKS ON THE MOVE-Broadcom, home lenders, First Solar

Reuters
·
Jan 09

Monte Rosa Therapeutics 11.125M share Secondary priced at $24.00

TIPRANKS
·
Jan 09

Press Release: Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering

Dow Jones
·
Jan 09

Assessing Monte Rosa Therapeutics (GLUE) Valuation After Its Strong 1 Year Share Price Momentum

Simply Wall St.
·
Jan 09

BUZZ-U.S. STOCKS ON THE MOVE-Sigma Lithium, Darden Restaurants, Nike

Reuters
·
Jan 08

Monte Rosa Therapeutics Is Maintained at Buy by Guggenheim

Dow Jones
·
Jan 08

Wells Fargo Reaffirms Their Buy Rating on Monte Rosa Therapeutics (GLUE)

TIPRANKS
·
Jan 08

BUZZ-U.S. STOCKS ON THE MOVE-Constellation Brands, General Motors, Ford

Reuters
·
Jan 08

U.S. RESEARCH ROUNDUP-Alcoa, BlackRock, Evercore

Reuters
·
Jan 08

Monte Rosa Therapeutics Inc : Jefferies Raises Target Price to $31 From $22

THOMSON REUTERS
·
Jan 08

BRIEF-Monte Rosa Therapeutics Inc - Terminates Sales Agreement Prospectus - SEC Filing

Reuters
·
Jan 08

Press Release: Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Dow Jones
·
Jan 08

BUZZ-U.S. STOCKS ON THE MOVE-Nvidia, Boeing, Lowe's

Reuters
·
Jan 08

Crude Oil Down 2%; ISM Services PMI Surges In December

Benzinga
·
Jan 08

Monte Rosa Shares Hit Highest Since 2021, Last up 43.7% as Heart Drug Shows Promise in Early-Stage Trial

THOMSON REUTERS
·
Jan 07

U.S. Stock Movement | Positive Phase 1 Trial Data for MRT-8102 Sends Monte Rosa Therapeutics (GLUE.US) Soaring Over 42% Pre-Market

Stock News
·
Jan 07

BUZZ-U.S. STOCKS ON THE MOVE-Hershey, Praxis Precision, Cal-Maine Foods

Reuters
·
Jan 07